Independent research Source-backed profiles No paid rankings
Peptide Provider Direct
the biostation logo
Unclaimed12 services cataloged

the biostation

Delray Beach, FL · Telehealth available

Visit provider website ↗

Provider overview

About the biostation

the biostation identifies Martin G. Bloom, MD, as chief medical officer, medical director, and co-founder. This listing records six current clinic addresses directly supported by official location pages and a telehealth pathway whose exact state coverage is not published. The clinic's current peptide menu is unusually broad and includes provider-advertised investigational or unclear-status compounds. Their inclusion here does not establish approval, lawful compounding, availability at every location, safety, efficacy, or suitability. No dispensing pharmacy or 503A/503B relationship is inferred.

At a glance

Market role
Direct patient-care provider
Care model
Telehealth and In person
Coverage
2 listed jurisdictions
Pharmacy pathway
Not publicly established

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

12 cataloged
01

Provider-advertised growth-hormone-related peptides

1

Hexarelin, IGF-1 LR3, tesamorelin, and sermorelin

These compounds appear in the clinic's current peptide menu; the directory does not establish regulatory status, availability, or expected outcomes.

Provider source ↗
02

Provider-advertised recovery compounds

1

PDA and pentosan polysulfate recovery pathways

The provider lists Pentadeca Arginate and pentosan polysulfate in a recovery category without directory-side safety or efficacy claims.

Provider source ↗
03

Medical weight management

1

Retatrutide, semaglutide, and tirzepatide programs

The current menu names these metabolic compounds; retatrutide remains provider-advertised and its regulatory and prescribing status should be confirmed directly.

Provider source ↗
04

Provider-advertised cognitive and cellular wellness

1

Pinealon, Synapsin, and NAD-related care

These offerings are grouped by the provider under cognitive and stress-related care; the listing does not repeat marketing outcome claims.

Provider source ↗
05

Provider-advertised immune-health peptides

1

Thymosin and VIP

The clinic names thymosin and VIP in its peptide catalog; current formulation and availability require confirmation.

Provider source ↗
06

Sexual health

1

PT-141

PT-141 is listed as a provider-advertised sexual-function offering subject to medical evaluation.

Provider source ↗
07

Provider-advertised skin and hair compounds

1

GHK-Cu and zinc-thymulin

The current menu lists these compounds in a skin and hair category without directory-side approval or outcome claims.

Provider source ↗
08

Provider-advertised longevity compounds

1

SS-31 and epithalon

The clinic lists SS-31 and epithalon under anti-aging; inclusion is a record of provider advertising, not an endorsement or regulatory determination.

Provider source ↗
09

Testing and ongoing care

1

Diagnostic blood testing and provider review

The practice describes testing across more than 100 biomarkers followed by an in-depth provider consultation and continued monitoring.

Provider source ↗
10

Hormone health

1

Hormone replacement care for men and women

Official location pages list testosterone and broader hormone-replacement services supported by diagnostic testing.

Provider source ↗
11

Infusion and nutrient services

1

IV nutrients, injections, and glutathione

The current service catalog includes IV nutrient therapy, nutrient injections, and glutathione at participating locations.

Provider source ↗
12

Telehealth care

1

Remote consultation and ongoing monitoring

The telehealth pathway includes remote history and results review, local laboratory work, a provider consultation, a personalized plan, and continued monitoring; exact states are not published.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

Continue comparing

Related provider profiles

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.